diroximel fumarate
Selected indexed studies
- Diroximel Fumarate. (, 2006) [PMID:33886179]
- Diroximel fumarate to treat multiple sclerosis. (Drugs Today (Barc), 2020) [PMID:32648853]
- Diroximel fumarate for multiple sclerosis. (Aust Prescr, 2022) [PMID:36382172]
_Worker-drafted node — pending editorial review._
Connections
diroximel fumarate is a side effect of
Sources
- Diroximel Fumarate. (2006) pubmed
- Diroximel fumarate to treat multiple sclerosis. (2020) pubmed
- Diroximel fumarate for multiple sclerosis. (2022) pubmed
- PMID:40489589 (2022) pubmed
- Diroximel Fumarate in Relapsing Forms of Multiple Sclerosis: A Profile of Its Use. (2021) pubmed
- Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data. (2022) pubmed
- Dimethyl Fumarate. (2006) pubmed
- Diroximel fumarate in the treatment of multiple sclerosis. (2020) pubmed
- Dimethyl Fumarate. (2012) pubmed
- Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: NEDA-3 After Re-Baselining in the Phase 3 EVOLVE-MS-1 Study. (2024) pubmed